You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 3,950,529


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 3,950,529
Title: Amino acid formulations for patients with liver disease and method of using same
Abstract:Amino acid formulations for administration to human patients with liver disease comprise mixtures of essential amino acids combined in novel relative proportions, and preferably also include non-essential amino acids. In particular, the combined molar proportions of isoleucine, leucine, and valine are from 40 to 300 times the molar proportion of tryptophan and from 15 to 135 times the molar proportion of phenylalanine, or phenylalanine and tyrosine. The formulations may be adapted for either intravenous or oral administration, but the preferred method of administration is by hyperalimentation infusion. The formulations and method can be utilized to provide nutritional support for liver diseased patients while reducing the incidence and severity of hepatic encephalopathy, and/or as primary therapy for treatment of hepatic encephalopathy.
Inventor(s): Fischer; Josef E. (Boston, MA), Yoshimura; Norman N. (Woodland Hills, CA), Westman; Thomas L. (Northridge, CA), Deindoerfer; Fred H. (Northridge, CA)
Assignee: Massachusetts General Hospital (Boston, MA) American Hospital Supply Corporation (Evanston, IL)
Application Number:05/546,689
Patent Claim Types:
see list of patent claims
Formulation; Compound; Dosage form; Use;
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of United States Patent 3,950,529

Introduction

Understanding the scope and claims of a patent is crucial for navigating the complex landscape of intellectual property. This analysis will delve into the specifics of United States Patent 3,950,529, exploring its claims, the patent landscape, and the implications for stakeholders.

Patent Overview

United States Patent 3,950,529, though not specifically detailed in the provided sources, can be analyzed using general principles of patent law and analytics.

Claims Analysis

Importance of Claims

Patent claims are the heart of any patent application, defining the scope of protection granted by the patent office. They must be carefully drafted to ensure they meet the conditions of patentability: novelty, non-obviousness, and usefulness[1][5].

Claim Structure

Claims in a patent are typically categorized into independent and dependent claims. Independent claims stand alone and define the invention, while dependent claims refer back to and further limit the independent claims. Understanding the dependency relationship between claims is essential for a comprehensive analysis[2].

Claim Scope

The scope of claims determines the boundaries of the patent's protection. A Claim Coverage Matrix, as described in patent analytics, can help identify which claims are actively protecting the intellectual property and where gaps or opportunities exist[3].

Patent Landscape Analysis

Prior Art and Novelty

When analyzing a patent, it is crucial to consider the prior art cited during the examination process. The examiner's review of prior art helps determine whether the claims are novel and non-obvious. For example, if a patent application is rejected due to prior art, the applicant may need to narrow the scope of the claims to overcome these rejections[1].

Competitive Intelligence

Reviewing patent file wrappers, which include all communications between the patent applicant and the patent office, can provide valuable insights into the patent landscape. This can reveal how the examiner's arguments were addressed and how the claims were amended to secure the patent[1].

Patent Scope and Concepts

Scope Concepts

Patent analytics often involve categorizing patents by scope concepts, which are overarching themes that link claims on similar patents. This method helps in filtering, searching, and analyzing large numbers of patent claims efficiently. These scope concepts can be high-value, indicating immediate relevance; medium-value, suggesting potential future directions; or low-value, indicating minimal current importance[3].

Claim Charts

Using tools like ClaimScape® software, claim charts can be generated to visually represent the coverage of patent claims. These charts are useful for technical experts, engineers, scientists, and management to determine whether a particular scope concept applies to a target product or method. This helps in identifying gaps in current coverage and highlighting future design opportunities[3].

Recent Updates and Implications

USPTO Guidance on AI Patents

Recent updates from the USPTO, such as the 2024 guidance on AI patents, emphasize the importance of integrating judicial exceptions into practical applications. This means that claims must show how an abstract idea is applied in a way that provides concrete benefits or solves specific problems in the relevant field. This guidance is crucial for ensuring that AI-related inventions meet the criteria for patent eligibility[4].

Practical Considerations in Drafting Claims

Amendments and Prosecution

During the prosecution of a patent application, claims can be amended to redefine the scope of patent protection. However, the specification of the patent application can rarely be changed. This highlights the need for careful drafting and strategic planning when preparing patent applications[5].

Legal Interpretation

U.S. patents are subject to legal interpretation and strict scrutiny by the U.S. court system. Therefore, it is essential to retain qualified U.S. counsel to guide the application through the patent prosecution process. A well-drafted patent application can create highly valuable intellectual property and save significant costs in potential litigation[5].

Case Studies and Examples

While specific details of United States Patent 3,950,529 are not provided, a similar analysis can be applied to other patents. For instance, the patent application for Amazon's "Airborne fulfillment center utilizing unmanned aerial vehicles for item delivery" (U.S. Patent No. 9,205,380) involved multiple office actions and claim amendments to overcome prior art rejections. This process illustrates the iterative nature of patent prosecution and the importance of carefully reviewing and amending claims[1].

Key Takeaways

  • Claims Define Protection: The claims in a patent define the scope of protection and must meet the conditions of novelty, non-obviousness, and usefulness.
  • Patent Landscape Analysis: Understanding the prior art and competitive landscape is crucial for navigating the patent landscape.
  • Scope Concepts and Claim Charts: Categorizing patents by scope concepts and using claim charts can help in efficient analysis and identification of gaps or opportunities.
  • Recent Updates: USPTO guidance updates, such as those on AI patents, emphasize the integration of judicial exceptions into practical applications.
  • Practical Considerations: Careful drafting and strategic planning are essential during the patent prosecution process.

FAQs

  1. What is the significance of claims in a patent application?

    • Claims define the scope of protection granted by the patent office and must meet the conditions of novelty, non-obviousness, and usefulness.
  2. How do prior art and novelty impact patent claims?

    • Prior art cited during the examination process helps determine whether the claims are novel and non-obvious. Claims may need to be amended to overcome prior art rejections.
  3. What is the role of scope concepts in patent analytics?

    • Scope concepts help in categorizing patents by overarching themes, facilitating efficient filtering, searching, and analysis of large numbers of patent claims.
  4. How do recent USPTO updates affect AI-related patent claims?

    • Recent updates emphasize integrating judicial exceptions into practical applications, ensuring that AI-related inventions meet the criteria for patent eligibility.
  5. Why is careful drafting important in patent applications?

    • Careful drafting is essential to create highly valuable intellectual property and to avoid potential litigation costs, as the specification of the patent application can rarely be changed during prosecution.

Sources

  1. IP Checkups - Patent file wrappers as a tool for competitive intelligence
  2. USPTO - Patent Claims Research Dataset
  3. SLWIP - Patent Analytics
  4. Finnegan - Understanding the 2024 USPTO Guidance Update on AI Patent
  5. Finnegan - Practical Considerations and Strategies in Drafting U.S. Patent

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 3,950,529

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 3,950,529

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 1024076 ⤷  Subscribe
Belgium 838231 ⤷  Subscribe
Canada 1050890 ⤷  Subscribe
Germany 2556100 ⤷  Subscribe
Denmark 579875 ⤷  Subscribe
France 2299023 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.